Sandoz gets final ok for $265 million direct purchaser settlement in US generic drug antitrust case
MLex Summary: Sandoz’s $265 million settlement agreement with direct purchasers in a multidistrict litigation over generic pharmaceuticals pricing has been granted final approval by a federal judge.See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article